Pacritinib and Telithromycin: Interaction Details

Brand names
Telithromycin
Ketek
Pacritinib
Vonjo
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Telithromycin

Brand name
  • Ketek

We don't have a drug information page for Telithromycin yet. Have a question about Telithromycin? Ask a pharmacist, free →

What Happens When You Take Pacritinib With Telithromycin

What can happen when they are taken together (rated Contraindicated)

Increased pacritinib exposure, an increased risk of pacritinib-related adverse effects and an increased risk of an increased risk of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Pacritinib must not be given together with a strong , since this combination can raise pacritinib exposure and may intensify adverse effects related to pacritinib. In addition, taking pacritinib with other drugs that prolong the may have an effect on QTc prolongation, which raises the risk of cardiac .

When such drugs are used together, should be corrected before and throughout pacritinib therapy, and QTc prolongation should be managed by interrupting pacritinib and by managing electrolytes. A study gave a single 400 mg dose of pacritinib on top of clarithromycin 500 mg twice daily for 5 days, and pacritinib rose 1.80-fold while rose 1.30-fold. Continued , and a clarithromycin regimen as used in clinical practice, could lead to an even greater increase in pacritinib exposure.1

The Pacritinib and Telithromycin Interaction, Explained

Telithromycin can raise the amount of pacritinib in your body, and both drugs can affect your heart rhythm. Telithromycin slows the liver enzyme () that normally breaks pacritinib down, so more pacritinib stays in your blood. That can mean more side effects. Both medicines can also lengthen the , an electrical timing change in the heart that can occasionally lead to a dangerous irregular rhythm.

This combination is normally not recommended. Please don't stop or change either medicine on your own. Talk with your pharmacist or doctor, who can review your options and, if the two are ever used together, tailor your treatment and monitor you more closely.

(strong plus pacritinib; ). Telithromycin inhibits CYP3A4-mediated pacritinib , increasing exposure. Pacritinib is not a , so higher exposure means greater effect and toxicity. Both agents prolong .

  • Magnitude: with clarithromycin 500 mg BID, a single 400 mg pacritinib dose gave 1.80-fold and 1.30-fold. Ongoing dosing may raise exposure further.
  • Onset: unspecified. Evidence: probable.
  • Management: avoid and consider a non-interacting alternative. If unavoidable, correct before and during therapy, monitor QTc and electrolytes, and manage QTc prolongation with pacritinib interruption and electrolyte management.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Pacritinib and Telithromycin Interact

The likely mechanism

of -mediated of pacritinib;

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Pacritinib and Telithromycin Interaction

The usual approach is to avoid this combination, so your prescriber may choose a different antibiotic or review your pacritinib plan.

  • Keep taking your medicines as prescribed until your care team advises otherwise, and tell them about every medicine you take.
  • If both are used together, your team may check and correct your potassium levels before and during treatment and may monitor your heart rhythm more closely.
  • If a QT change appears, your team may pause pacritinib and manage your electrolytes.
  • Report fainting, a racing or irregular heartbeat, or dizziness to your doctor right away.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Pacritinib or Telithromycin need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: VONJO oral capsules, pacritinib oral capsules

    In a study, giving a single 400 mg dose of pacritinib together with clarithromycin (a strong ) 500 mg twice daily for 5 days raised the pacritinib 1.80-fold and the 1.30-fold. Continued and a clarithromycin regimen as used clinically may lead to a further rise in pacritinib exposure.1

Pacritinib and Telithromycin: Common Questions

How serious is the Pacritinib and Telithromycin interaction?

It is rated . These should generally not be used together.

How is the Pacritinib and Telithromycin interaction managed?

The usual approach is to avoid this combination, so your prescriber may choose a different antibiotic or review your pacritinib plan. Keep taking your medicines as prescribed until your care team advises otherwise, and tell them about every medicine you take. If both are used together, your team may check and correct your potassium levels before and during treatment and may monitor your heart rhyt… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Pacritinib and Telithromycin Interaction

Ask in your own words about taking Pacritinib and Telithromycin together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: VONJO(R) oral capsules, pacritinib oral capsules. CTI BioPharma Corp (per FDA), Seattle, WA, 2024. DailyMed
Was this write-up helpful?

Other Serious Interactions of Pacritinib and Telithromycin

Also serious with Telithromycin

Also serious with Pacritinib

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Telithromycin

With Pacritinib

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together. This interaction.
  • Major Potentially serious — often needs a change or close monitoring.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.